Top Biotech Companies (3,713)
Sun World International, LLC develops, breeds and licenses proprietary fruit varieties worldwide, specializing in table grapes and expanded programs in citrus, mango, stone fruit, cherry and avocado. The company manages variety rights, supports licensed growers and marketers, and advances breeding through genetics, technology and sustainability initiatives to deliver differentiated fruit varieties and licensed brands to global markets.
Millennium Health is an accredited specialty laboratory with over a decade of experience delivering timely, accurate, clinically-actionable information through our nationwide medication monitoring and drug testing services. Drug testing is used by substance use disorder and pain management providers to obtain objective information about patients’ recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment...
binx health is a health technology company dedicated to expanding convenient and equitable access to healthcare. The company specializes in point-of-care molecular diagnostics, specifically with its FDA-cleared, CLIA-waived binx io platform, which enables rapid diagnosis and treatment of chlamydia and gonorrhea infections in about 30 minutes. Its mission is to improve community health outcomes by providing high-quality diagnostic solutions tailored...
Helping Make Research Possible We are helping make research possible by supplying scientists worldwide with the assay kits, antibodies, proteins, and biochemicals to advance their research. We know the scientific community needs more than our products, so our 100 in-house scientists, the same who design and develop our products, connect with researchers to answer questions, provide resources, and offer contract research...
Asklepios BioPharmaceutical, Inc. (AskBio) is a leading clinical-stage adeno-associated virus (AAV) gene therapy company dedicated to improving the lives of patients with rare disorders and other diseases. We’ve built a foundation of therapeutic programs, AAV manufacturing and a rich portfolio of patented technology. Our therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases with clinical trials underway for Pompe...
We are a group of engineers and innovators, working together to create and launch ingenious products and companies today for a sustainable tomorrow. Our vision is to paradigm shift R&D in the country, making it a competitive driver in the transformation of the national economy. With a mission to seed intellectual potential for a sustainable future, eiGroup embraces an integrated approach...
Again is a carbon utilization company that transforms carbon emissions into valuable chemicals and proteins. By combining millennia-old bacteria with cutting-edge technology and AI-powered biocatalysts, it develops biomanufacturing solutions that convert CO2 waste into carbon-negative chemicals, enabling industrial leaders to upgrade their existing infrastructure and turn waste gases into critical products.
Valkai provides an AI operating system for life sciences, designed to accelerate the path from discovery to patient impact. Their platform connects life sciences data to support search, automation, and workflow management, enabling companies to centralize validated data and bring new therapies and devices to patients faster.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to...
Amgen's Top Stability & Growth Strengths
Strong Revenue Growth: 2025 results show total revenues up 10% to $36.8 billion and guidance for 2026 at $37.0–$38.4 billion signals continued top‑line expansion.
Diversified Revenue Streams: Company updates indicate a broad base with roughly 40 marketed products and 14 blockbusters in 2024, and in 2025 eighteen products reached record sales with notable growth from Repatha, TEZSPIRE, EVENITY, BLINCYTO, and rare‑disease brands.
Strong Market Position & Advantage: Evidence suggests Amgen is widely regarded as a leader among large‑cap biotechs with significant scale and an expanded rare‑disease footprint following the Horizon acquisition.
Leading the field in the discovery of drugs that modulate the effects of cortisol. The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects...
In today's interconnected world, we are currently faced with many global challenges and opportunities surrounding infectious diseases. At Alveo, we're tackling these head-on by creating technology platforms that provide rapid, reliable, and economical cloud-based diagnostics for use by everyone, anytime, everywhere.
DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and...
TIENS Group is a global multinational conglomerate founded in 1995 by Li Jinyuan in Tianjin, China. The company specializes in biotechnology, health management, and wellness, operating in over 190 countries. It offers a wide range of dietary supplements, healthcare equipment, and beauty products, aiming to improve global health by integrating nature with modern science and technology to provide a better...
Hamilton Company is a global enterprise with headquarters in Reno, Nevada; Franklin, Massachusetts; and Bonaduz, Switzerland and subsidiary offices throughout the world. We are an industry leader in the design and manufacture of liquid handling, process analytics, robotics and automated storage solutions. For more than 60 years, Hamilton has been meeting customer needs with a combination of quality materials and skilled...
Medical Leverage is a communications company that partners with pharmaceutical, biotech, and medical device companies to promote products and services through education, specializing in KOL and peer-to-peer management, digital formatting, medical education, medical writing, and premarket launch planning.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Stryker's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double-digit annual sales expansion through 2025, with management guiding to continued organic growth into 2026.
Strong Market Position & Advantage: Evidence highlights leadership in orthopedic robotics and top-tier standings among global medtech peers, with notable share in joint replacement and integrated OR technologies.
Diversified Revenue Streams: Multiple segments and recent vascular-focused acquisitions broaden growth drivers and reduce reliance on any single category.
A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and infection prevention solutions and services. With annual sales of $12 billion and more than 44,000 associates, Ecolab delivers comprehensive solutions, data-driven insights and personalized service to advance food safety, maintain clean and safe environments, optimize water and energy use, and improve...
Ecolab's Top Stability & Growth Strengths
Profitability: Record sales, earnings per share, and operating margins in 2024 and 2025 indicate sustained margin improvement. Feedback suggests continued expansion is expected in 2026 supported by pricing discipline, productivity, and higher‑margin services.
Strong Market Position & Advantage: Ecolab is consistently characterized as a global leader across water, hygiene, and infection prevention with broad industry reach and high customer retention. Feedback suggests external accolades and large-scale operations reinforce a durable competitive moat.
Innovation-Driven Growth: Expansion into high-growth areas like hyperscale data centers, microelectronics, and life sciences is supported by acquisitions and digital services. Feedback suggests AI-enabled analytics, performance-based contracts, and a growing backlog are fueling future growth.
Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders and cancer.
Contineum Therapeutics is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for neurology, inflammation, and immunology (NI&I) indications with significant unmet need.
































